Tarsus Pharmaceuticals, Inc. (TARS)

NASDAQ: TARS · Real-Time Price · USD

68.88

-1.14 (-1.63%)

Aug 13, 2026, 4:00 PM EDT - Market closed

Tarsus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	3,023	3,484	2,123	693	392	466
Market Cap Growth	43.01%	64.09%	206.51%	76.81%	-15.87%	-44.55%
Enterprise Value	2,662	3,139	1,904	495.15	194.23	293.91
Last Close Price	68.88	81.88	55.37	20.25	14.66	22.50

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	97.48	-	-	-	-
PS Ratio	4.99	7.72	11.61	39.71	15.18	8.17
PB Ratio	8.60	10.15	9.46	3.52	2.03	2.79
P/TBV Ratio	8.70	10.18	9.63	3.08	1.87	2.77
P/FCF Ratio	53.97	-	-	-	-	147.29
P/OCF Ratio	40.76	-	-	-	-	124.26

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.39	6.96	10.41	28.38	7.52	5.15
EV/FCF Ratio	47.53	-	-	-	-	92.95

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.21	0.21	0.32	0.15	0.10	0
Debt / FCF Ratio	1.30	-	-	-	-	-
Net Debt / Equity Ratio	-1.09	-1.00	-0.98	-1.00	-1.02	-1.03
Net Debt / EBITDA Ratio	8.16	4.99	1.84	1.39	3.17	14.51
Net Debt / FCF Ratio	-6.73	15.46	2.60	1.66	3.99	-54.34
Asset Turnover	1.03	0.96	0.57	0.07	0.13	0.33
Inventory Turnover	9.31	8.78	4.48	1.03	-	-
Quick Ratio	3.12	3.72	4.21	6.64	14.30	14.98
Current Ratio	3.20	3.85	4.42	6.93	14.61	15.33
Return on Equity (ROE)	-13.47%	-23.39%	-54.83%	-69.71%	-34.53%	-8.31%
Return on Assets (ROA)	-8.27%	-14.63%	-37.53%	-58.03%	-30.84%	-6.89%
Return on Invested Capital (ROIC)	-3704.96%	-3817.65%	-5520.56%	-	-	-
Return on Capital Employed (ROCE)	-11.26%	-19.64%	-45.94%	-64.93%	-33.02%	-7.28%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
FCF Yield	1.85%	-	-	-	-	0.68%
Buyback Yield / Dilution	-7.95%	-11.11%	-27.98%	-19.35%	-19.78%	-231.12%
Total Shareholder Return	-7.95%	-11.11%	-27.98%	-19.35%	-19.78%	-231.12%

SEC Filings: 10-K · 10-Q